Emtriva (Gilead Sciences, Inc.)
Welcome to the PulseAid listing for the Emtriva drug offered from Gilead Sciences, Inc.. This Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Gilead Sciences, Inc. |
NON-PROPRIETARY NAME: | EMTRICITABINE |
SUBSTANCE NAME: | EMTRICITABINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2003-07-02 |
END MARKETING DATE: | 0000-00-00 |
Emtriva HUMAN PRESCRIPTION DRUG Details:
Item Description | Emtriva from Gilead Sciences, Inc. |
LABELER NAME: | Gilead Sciences, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 2003-07-02 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 61958-0601_9d004165-8e41-4b34-97e5-fca88062969c |
PRODUCT NDC: | 61958-0601 |
APPLICATION NUMBER: | NDA021500 |
Other EMTRICITABINE Pharmaceutical Manufacturers / Labelers: